A Diagnostic Accuracy Study to Evaluate the feasibility of the CardioWatch 287 in detecting heart rate and rr-intervals

MMT Swiss Connect0 sites100 target enrollmentTBD

ConditionsAll patients presenting at CCN that are scheduled for a resting ECG qualify for participation

Overview

Phase: N/A
Intervention: Not specified
Conditions: All patients presenting at CCN that are scheduled for a resting ECG qualify for participation
Sponsor: MMT Swiss Connect
Enrollment: 100
Status: Recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

2 years ago

Study Type

Observational non invasive

Investigators

Sponsor

MMT Swiss Connect

Eligibility Criteria

Inclusion Criteria

•Patients at CCN, scheduled for a resting ECG
•Aged 18 years or above

Exclusion Criteria

•Under the age of 18
•Subjects who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the subject's participation in this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed

N/A

Feasibility Study to Assess Diagnostic Accuracy of Pathological Complete Response with Core Needle BiopsyInvasive Breast Cancer

JPRN-UMIN000012035Yokohama City University Medical Center80

Recruiting

Phase 1

se of axillary Ultrasound and FNAC in Breast CarcinomaHealth Condition 1: null- Breast Cancer

CTRI/2018/02/011793Somendra Pal Singh team

Recruiting

N/A

Study of performance of Cxbladder tests to indicate whether patients are at low or high risk of bladder cancer when presenting with blood in urine.Bladder cancerhematuriaCancer - BladderRenal and Urogenital - Other renal and urogenital disorders

ACTRN12618000058279Pacific Edge Pty Ltd500

Active, Not Recruiting

Phase 1

A clinical study in men with prostate cancer undergoing surgery to assess the accuracy of 99mTc-MIP-1404 imaging as compared to pathology resultsProstate Cancer within prostate gland and metastatic prostate cancer in regional lymph nodesMedDRA version: 14.1Level: LLTClassification code 10007113Term: Cancer of prostateSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]

EUCTR2012-001864-30-BEMolecular Insight Pharmaceuticals, Inc100

Active, Not Recruiting

N/A

Phase 2 study to assess the effectiviness of the investigational drug 99mTc-MIP-1404 in detecting prostate cancer tissue within the prostate gland and elsewhere in human body.Prostate Cancer within prostate gland and metastatic prostate cancer in regional lymph nodesMedDRA version: 15.0Level: LLTClassification code 10007113Term: Cancer of prostateSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]

EUCTR2012-001864-30-HUMolecular Insight Pharmaceuticals, Inc100